{"name":"Genoscience Pharma","slug":"genoscience-pharma","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMilwFBVV95cUxNeC1xTV9JMmNIcnQ4aHp3NzBVakdyVngxWUZESUx4b2ZRRi1pR3VwVFlxdGVZVEE4dzVDTlptSWhleXMtc0NJdnBvNFMyWXlCak1EMGloXzFhQWFmRm91M3ZfdXlNTHhiQlVxbzNEUmQ5ejdPYXE3djhxZm1aMl95MjFxem1Bbjk3NVZwZVc0ODVOREdNX1RN?oc=5","date":"2026-03-20","type":"trial","source":"openPR.com","summary":"Hepatic Tumor Clinical Trial Landscape Strengthens as 75+ - openPR.com","headline":"Hepatic Tumor Clinical Trial Landscape Strengthens as 75+","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiygFBVV95cUxOUVdaZlFFU1g1N2k2dFdGVnd6QVBhYWFfaWFXOVNYRkFnRC1VbDBlaGpXSnptTWkxV3Z2Qk9MN2M4QWhZcmFMaFIyV2FqR2pZUFhxSlBWRVJKZTFVMEdfMXF6ZGR6d2h2bVBZSllwX0c1NzNCVEJpUEQ0Q1JXdDFoZ2FvNTMwR2R4TnVIU0ZOTTB0X1IxVTVDQzBpZG5YeE9nTDZPbWRwX0ZKNGFQcHF2V1NJdmdFMFVwdDhYMEYtZkZCNEJHNEp0VXBR?oc=5","date":"2024-10-29","type":"pipeline","source":"European Medical Journal","summary":"Therapeutic Advances in Gastrointestinal Cancers: Immuno-oncology and Beyond - European Medical Journal","headline":"Therapeutic Advances in Gastrointestinal Cancers: Immuno-oncology and Beyond","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisAFBVV95cUxQOElnLVp5M1hHd0lIRTcyQ3llWkM1dTFkRzd4NXUzcXZ4MkdfTXdnQWh4RmVqOE41Sy1iYk5wZTNXRk1XdXlUVDNwVW5TTWVGSlVEUkRiOHFFQTA2eWkyamJUMVBuckxVaVczS0NnNlFzMGg5eUxaWmk4THpBRFZJQ2JVcGxlWGFvUHc2VnJZU1pMMFgyc29ITC1BZW44SlA3N05YSktqd2tackZrZmw3Sg?oc=5","date":"2023-02-10","type":"regulatory","source":"CancerNetwork","summary":"Ezurpimtrostat Receives FDA Orphan Drug Designation for Liver Cancer Subtype - CancerNetwork","headline":"Ezurpimtrostat Receives FDA Orphan Drug Designation for Liver Cancer Subtype","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimgFBVV95cUxQbl9vRzFRRm81VThMX2dJRFRsQXRjUTNRQnd1TWZXekNHRVBxUkd4SXdUaWhvMDNOZm5pNUpGQjl6Q3hOVm5TZWZpME9xYU0tYjBZeTJ5RVFRRUtuTlJ0VVFOUkJXRFlpTTM0TktJRldiblFjdkFtZmNTdTNJYWIwZ0J5N09EaUNiNlcyLXI1T3F1VUZCTVJNRlpR?oc=5","date":"2023-02-01","type":"regulatory","source":"Targeted Oncology","summary":"FDA Grants ODD to Ezurpimtrostat for Hepatocellular Carcinoma - Targeted Oncology","headline":"FDA Grants ODD to Ezurpimtrostat for Hepatocellular Carcinoma","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiogJBVV95cUxPQkg5Z01hRzAxYkxRQ1dmeTdfUFp5ZVVURVNsdHJvSUgzOWY2TVJfLVA5UzhUZTdPcnd1YXU4SDJmaXM3b3lsd2o0SnQ1endQZmN0UTVSSnltNlpVX29BMHZVd01QWFV4TEdUd3VBdnlIMTNXY0MtRlBqOGZwT3pySWtFM2pnM1AwS3NXU1p4WlhqNUdjelUtQnFnVmpMcUh2ZjdaakhqZWVsM0FpZkVSR2FZWTlXOVF4SHNSeGtxTDlYenVzSk4yWnM4V2tFSm5kQmZKN1lPNXNxUUVSOEZpWGUxejExT2dFMW03STNWemFlMjhBUWJYLVh0RjlPdmpqSmFaU1pLZkxuMDRSYjZzYjJjVnRTbmdLMXJHRFlvQk1zUQ?oc=5","date":"2022-12-05","type":"pipeline","source":"European Medical Journal","summary":"Targeting Fibroblast Growth Factor Receptor Alterations in Cholangiocarcinoma and Other Solid Tumours: A New Frontier in Personalised Medicine - European Medical Journal","headline":"Targeting Fibroblast Growth Factor Receptor Alterations in Cholangiocarcinoma and Other Solid Tumours: A New Frontier in","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiZ0FVX3lxTFBQSWJpbEh2NmFrZTdoRTk2S3BGSFJTVHFHZXZOeWNwVHphMmFUQVFRMnMwX05PbWh2dDlrNUpZNFdOTVBPaktibXl6TkJWSHU1ZmI3YjB4UTNiMkYzZExYeUo2am5LZTQ?oc=5","date":"2022-01-22","type":"pipeline","source":"MedPage Today","summary":"Potential New First-Line Options for Unresectable Hepatocellular Carcinoma - MedPage Today","headline":"Potential New First-Line Options for Unresectable Hepatocellular Carcinoma","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitgFBVV95cUxOQzZfZmhSTEd2Zmpma0RPdm1jVjYwMmdkTXdOV0pfRXRIQUcxbm5uWVBTYm9SSWt5czg0aTBrZ3kwZVl1eENobThwZDZhRVgtVkk3N3oyLXBxYXYzRGVONGFiY3BBSjhqOFE2TzZFRFpNYXB1Q0QtSW9aMG1jVTdwSzEwUVFCbjZ2WHB4NmVkWVFzNDdqZ0g2alh1bE90WnVSXzk3VV95S1RrdE9rT3o0RDZJY0VFZw?oc=5","date":"2021-12-17","type":"trial","source":"MedCity News","summary":"Ipsen gets rights to failed Genfit NASH drug, now in Phase 3 for rare liver disease - MedCity News","headline":"Ipsen gets rights to failed Genfit NASH drug, now in Phase 3 for rare liver disease","sentiment":"negative"},{"url":"https://news.google.com/rss/articles/CBMirwFBVV95cUxPd1djMXNFOUk3d2diR1g2WkFhMVcyMlRQd25Mb3hnTlJjbHBaWW9ScTkzS1hsZm15LTl6QjZ0ckhhdC1Valc0Ym1hMlVKY0tuY0dsTjJSRWRxV2lFOVROWWFJU1VjMnRkODFUQkNTWW5HMEV0bWlaamRzOTRITk5qRnlsdUFNcGhBNUVwQXhrOXdpdGNQd0lodzhleUJEWlhkZVBId1dadk1jbU11VEpj?oc=5","date":"2021-04-19","type":"pipeline","source":"Healio","summary":"Neoadjuvant cemiplimab leads to tumor necrosis in HCC - Healio","headline":"Neoadjuvant cemiplimab leads to tumor necrosis in HCC","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiugFBVV95cUxNTTVGYUpzV256Z3Y4WjU1SmdlWDdicjlEOXBKNlhYUmE5cWpaQXAzbklTVGFNZ3RwbFU1N0xZX09EYW5xWEFYRGk1bkhfQmxNR2prRWZheG10S0FXYk5FU3A0UXFqMG44b0p1Tl9EYktjbmdQaFg4NFBQbm1NRGVGcGQtMUo1dTYzbnJLcjV4YklRbnJ5Y3BCUjZTYmhGY2FiZk9YNXlTYUo2cEVBQ01KMjFBNDZETGg4aHc?oc=5","date":"2020-10-12","type":"pipeline","source":"News-Medical","summary":"Genoscience Pharma's GNS561 shows potential against SARS-CoV-2 in vitro - News-Medical","headline":"Genoscience Pharma's GNS561 shows potential against SARS-CoV-2 in vitro - News","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}